Story
KKR Stock Slides on Report of Distressed China Property Sale

Summary
Shares of KKR & Co. declined after a report revealed the investment firm is seeking to sell a portfolio of Chinese commercial real estate at significant discounts, underscoring the severe downturn in that market.
KKR & Co. (NYSE: KKR) shares fell 3.7% in mid-day trading Monday after a report that the private equity firm is moving to sell nine commercial real estate properties in China at deeply discounted prices, highlighting the persistent weakness in the country's property sector.
China Portfolio Write-Down
According to a Bloomberg report published Monday, KKR is marketing the assets with implied valuations of roughly 50% to 60% of their original purchase prices. The expected proceeds are reportedly only sufficient to repay the bank loans used to acquire the properties, signaling a potential total loss of the firm's equity investment.
The portfolio includes a high-end residential complex in Beijing and a hotel on Shanghai's Bund waterfront, which were acquired near the market's peak in 2019. The move underscores the scale of the challenges facing investors exposed to China's prolonged commercial real estate downturn, which has seen both investment and sales contract sharply.
AdMarket Reaction and Sector Headwinds
The negative sentiment from the property sale overshadowed a positive analyst action. HSBC reiterated its Buy rating on KKR and raised its price target to $121 from $118, citing confidence in the firm's long-term outlook. However, investors focused on the immediate impact of the reported real estate write-downs.
KKR's stock traded at $97.49, well below its 52-week high of $153.87. The decline came amid a mixed session for the broader market and reflects ongoing concerns for the alternative asset management sector. Peers such as Blackstone and Apollo Global Management have also faced headwinds in 2026 due to macroeconomic uncertainties and concerns over the private credit market.
Read next
More on Stocks
Polymarket Sues NY Attorney General in Escalating Dispute Over Prediction Market Regulation
Prediction market platform Polymarket has filed a lawsuit against New York Attorney General Letitia James, seeking to block state regulation just hours after her office sued the company for allegedly promoting illegal gambling.

ADARx Pharmaceuticals Prices IPO at $17 Per Share, Raising $446.3 Million
Biotechnology firm ADARx Pharmaceuticals has priced its initial public offering of 26.25 million shares at $17.00 each, aiming to raise approximately $446.3 million. The IPO is accompanied by a concurrent private placement with pharmaceutical giant AbbVie.

OpenAI to Preview Cybersecurity-Focused GPT-6 Model, Fortune Reports
The AI research firm is expected to unveil GPT-6 Cyber within days at its developer event, according to a report, highlighting the growing focus on AI for combating security threats.

Tesla to Formally Launch Semi Truck Production at Nevada Factory Event
Tesla is officially rolling out its long-awaited Semi electric truck at an inauguration event for its Nevada factory, marking a key milestone years after the vehicle's initial unveiling.